narhex life sciences float

My understanding is that it wasn't oversubscribed. They were still chasing applications right up until a few days prior to the 'official' closing date of the float.

Does anyone know if they managed to raise the minimum subscription for this float??

The float does have a bad smell about it, with inter-related transactions, debt to equity swaps for former creditors of the previous company which is subject to DOCA. I doubt it will list at a premium, considering the amount they are looking to raise. I would think that too many free float shares would hit the martket including previous disgruntled creditors.

That is the reason for my non-involvement in this float.

Good luck all............

Cheers Freakme